Skip to main content
Clinical Trials/IRCT20180924041107N1
IRCT20180924041107N1
Completed
Phase 2

A clinical trial to investigate effectiveness of Sovodak on viral load in patients with concurrent hepatitis C and HIV-1

Tabriz University of Medical Sciences0 sites22 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Condition 1: Hepatitis C and HIV. Condition 2: Human immunodeficiency virus.
Sponsor
Tabriz University of Medical Sciences
Enrollment
22
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients infected with HIV virus who get anti retroviral treatments and simultaneously infected with hepatitis C virus.

Exclusion Criteria

  • patients who previously received treatments for hepatitis C
  • patients with kidney disease
  • patients with advanced cirrhosis

Outcomes

Primary Outcomes

Not specified

Similar Trials